Profil
Marie-Eve Charrois is currently the Vice President-Regulatory Affairs at IMV, Inc. Prior to this, she worked as the Director-Regulatory Affairs at Medicago, Inc. and as the Manager-Site Conformance at GlaxoSmithKline Vaccines SRL.
She holds a graduate degree from Université Laval.
Aktive Positionen von Marie-Eve Charrois
| Unternehmen | Position | Beginn |
|---|---|---|
| IMV INC. | General Counsel | - |
Ehemalige bekannte Positionen von Marie-Eve Charrois
| Unternehmen | Position | Ende |
|---|---|---|
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | General Counsel | - |
Glaxosmithkline Vaccines Srl
 Glaxosmithkline Vaccines Srl BiotechnologyHealth Technology Glaxosmithkline Vaccines Srl engages in the development, production, and sale of biological preparations against infectious diseases. It offers vaccines for babies and children, teenagers and adults, travelers, and elderly people. The company was founded by Achille Sclavo in 1904 and is headquartered in Siena, Italy. | Corporate Officer/Principal | - |
Ausbildung von Marie-Eve Charrois
| Université Laval | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IMV INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
Glaxosmithkline Vaccines Srl
Glaxosmithkline Vaccines Srl BiotechnologyHealth Technology Glaxosmithkline Vaccines Srl engages in the development, production, and sale of biological preparations against infectious diseases. It offers vaccines for babies and children, teenagers and adults, travelers, and elderly people. The company was founded by Achille Sclavo in 1904 and is headquartered in Siena, Italy. | Health Technology |
